CRISPR screens reveal MCT1-driven metabolic escape from SMAD3 inhibition as a therapeutic vulnerability.

Journal: Molecular cancer •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Matvere A, Menchon G, Martinetti L, et al. (2026). "CRISPR screens reveal MCT1-driven metabolic escape from SMAD3 inhibition as a therapeutic vulnerability.". Molecular cancer. https://doi.org/10.1186/s12943-026-02757-9